Tel Aviv - Delayed Quote ILA
Enlivex Therapeutics Ltd. (ENLV.TA)
356.70
-10.20
(-2.78%)
At close: May 18 at 3:49:59 PM GMT+3
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ENLV.TA | -- | -- | -- | -- |
| S&P 500 | 13.31% | 2.67% | 7.78% | 13.74% |
Upgrades & Downgrades
| Maintains | D. Boral Capital: Buy to Buy | 4/21/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 4/3/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/24/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/3/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 2/7/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 12/11/2024 |
Related Tickers
SCNI Scinai Immunotherapeutics Ltd.
2.9100
+5.43%
BCLI Brainstorm Cell Therapeutics Inc.
1.3200
+13.79%
CGEN Compugen Ltd.
1.3900
+1.46%
NRXP NRx Pharmaceuticals, Inc.
2.4500
+2.08%
URGN UroGen Pharma Ltd.
7.31
-25.79%
IVVD Invivyd, Inc.
0.7767
+10.33%
KLTO Klotho Neurosciences, Inc.
0.2246
+14.01%
CABA Cabaletta Bio, Inc.
2.0300
+12.15%
CNSP CNS Pharmaceuticals, Inc.
1.2800
+1.59%
HCWB HCW Biologics Inc.
8.95
+9.15%